JC CHEMICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,170 KRW | +0.65% |
|
-0.80% | -15.25% |
| 2023 | JC Chemical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
| 2021 | JC Chemical Co., Ltd.(KOSDAQ:A137950) added to S&P Global BMI Index | CI |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 75,484 | 1,31,424 | 1,46,709 | 2,01,176 | 1,45,831 | 1,59,887 |
| Enterprise Value (EV) 1 | 1,41,560 | 2,30,638 | 2,52,218 | 3,34,366 | 2,72,543 | 2,53,482 |
| P/E ratio | 17.7 x | 11.2 x | 18.7 x | 6.14 x | 7.15 x | 7.7 x |
| Yield | 1.51% | 1% | 1.35% | 1.64% | 2.41% | - |
| Capitalization / Revenue | 0.42 x | 0.65 x | 0.55 x | 0.51 x | 0.29 x | 0.36 x |
| EV / Revenue | 0.78 x | 1.14 x | 0.94 x | 0.85 x | 0.53 x | 0.58 x |
| EV / EBITDA | 10.6 x | 12 x | 8.88 x | 6.82 x | 5.11 x | 5.76 x |
| EV / FCF | 51.7 x | -7.98 x | -19.1 x | -16.9 x | 15.7 x | 6.82 x |
| FCF Yield | 1.93% | -12.5% | -5.24% | -5.91% | 6.37% | 14.7% |
| Price to Book | 1.06 x | 1.4 x | 1.45 x | 1.53 x | 0.99 x | 0.97 x |
| Nbr of stocks (in thousands) | 19,038 | 21,904 | 21,962 | 21,962 | 21,962 | 21,962 |
| Reference price 2 | 3,965 | 6,000 | 6,680 | 9,160 | 6,640 | 7,280 |
| Announcement Date | 20/03/19 | 18/03/20 | 12/03/21 | 14/03/22 | 14/03/23 | 14/03/24 |
1KRW in Million2KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 1,81,261 | 2,02,369 | 2,67,695 | 3,92,923 | 5,11,666 | 4,39,247 |
| EBITDA 1 | 13,417 | 19,203 | 28,401 | 49,028 | 53,335 | 43,973 |
| EBIT 1 | 9,024 | 12,968 | 19,188 | 39,777 | 42,649 | 32,097 |
| Operating Margin | 4.98% | 6.41% | 7.17% | 10.12% | 8.34% | 7.31% |
| Earnings before Tax (EBT) 1 | 3,270 | 14,953 | 11,373 | 40,859 | 29,018 | 30,111 |
| Net income 1 | 4,263 | 11,391 | 7,831 | 32,763 | 20,399 | 20,772 |
| Net margin | 2.35% | 5.63% | 2.93% | 8.34% | 3.99% | 4.73% |
| EPS 2 | 223.9 | 534.1 | 356.9 | 1,492 | 928.8 | 946.0 |
| Free Cash Flow 1 | 2,736 | -28,901 | -13,205 | -19,745 | 17,351 | 37,179 |
| FCF margin | 1.51% | -14.28% | -4.93% | -5.03% | 3.39% | 8.46% |
| FCF Conversion (EBITDA) | 20.39% | - | - | - | 32.53% | 84.55% |
| FCF Conversion (Net income) | 64.17% | - | - | - | 85.06% | 178.99% |
| Dividend per Share 2 | 60.00 | 60.00 | 90.00 | 150.0 | 160.0 | - |
| Announcement Date | 20/03/19 | 18/03/20 | 12/03/21 | 14/03/22 | 14/03/23 | 14/03/24 |
1KRW in Million2KRW
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 66,075 | 99,214 | 1,05,509 | 1,33,189 | 1,26,713 | 93,595 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 4.925 x | 5.167 x | 3.715 x | 2.717 x | 2.376 x | 2.128 x |
| Free Cash Flow 1 | 2,736 | -28,901 | -13,205 | -19,745 | 17,351 | 37,179 |
| ROE (net income / shareholders' equity) | 3.48% | 14.7% | 7.82% | 29.5% | 14.1% | 13.9% |
| ROA (Net income/ Total Assets) | 3.52% | 3.95% | 5.02% | 8.85% | 8.48% | 6.6% |
| Assets 1 | 1,21,012 | 2,88,150 | 1,56,060 | 3,70,171 | 2,40,624 | 3,14,878 |
| Book Value Per Share 2 | 3,730 | 4,281 | 4,608 | 5,980 | 6,715 | 7,511 |
| Cash Flow per Share 2 | 710.0 | 619.0 | 691.0 | 601.0 | 407.0 | 914.0 |
| Capex 1 | 16,856 | 31,243 | 11,504 | 9,440 | 8,123 | 8,650 |
| Capex / Sales | 9.3% | 15.44% | 4.3% | 2.4% | 1.59% | 1.97% |
| Announcement Date | 20/03/19 | 18/03/20 | 12/03/21 | 14/03/22 | 14/03/23 | 14/03/24 |
1KRW in Million2KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -15.25% | 98.94M | |
| -13.20% | 484M | |
| -21.38% | 321M | |
| -9.54% | 241M | |
| -13.89% | 216M | |
| +20.19% | 197M | |
| +40.15% | 109M | |
| -7.44% | 75.75M |
- Stock Market
- Equities
- A137950 Stock
- Financials JC Chemical Co., Ltd.